Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Current Assets (2016 - 2025)

Historic Current Assets for STRATA Skin Sciences (SSKN) over the last 14 years, with Q3 2025 value amounting to $14.3 million.

  • STRATA Skin Sciences' Current Assets fell 1012.59% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year decrease of 1012.59%. This contributed to the annual value of $16.6 million for FY2024, which is 676.83% up from last year.
  • STRATA Skin Sciences' Current Assets amounted to $14.3 million in Q3 2025, which was down 1012.59% from $13.8 million recorded in Q2 2025.
  • STRATA Skin Sciences' Current Assets' 5-year high stood at $24.1 million during Q1 2021, with a 5-year trough of $13.2 million in Q1 2024.
  • Its 5-year average for Current Assets is $17.6 million, with a median of $16.6 million in 2024.
  • In the last 5 years, STRATA Skin Sciences' Current Assets crashed by 3492.59% in 2024 and then skyrocketed by 1991.84% in 2025.
  • Over the past 5 years, STRATA Skin Sciences' Current Assets (Quarter) stood at $20.0 million in 2021, then decreased by 24.63% to $15.1 million in 2022, then rose by 3.26% to $15.5 million in 2023, then rose by 6.77% to $16.6 million in 2024, then fell by 14.0% to $14.3 million in 2025.
  • Its last three reported values are $14.3 million in Q3 2025, $13.8 million for Q2 2025, and $15.9 million during Q1 2025.